Our Pricing

Private Semaglutide Injections UK: Fast Access to Wegovy

Published on: June 03, 2026

Looking for private semaglutide injections UK without lengthy NHS waiting lists? At Cured Pharmacy, you can access genuine UK-licensed Wegovy (semaglutide) from £79.00, with a free online consultation completed in under 3 minutes by our UK-registered clinical team. All treatments are dispensed by our GPhC-registered pharmacy and delivered discreetly to your door.

How Private Semaglutide Injections Work for Weight Loss

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that mimics a natural hormone your body produces after eating [1]. By activating GLP-1 receptors in the brain, pancreas, and digestive system, semaglutide reduces appetite, slows gastric emptying, and improves blood sugar regulation—creating the conditions for sustained weight loss.

In the landmark STEP 1 clinical trial, adults using once-weekly semaglutide 2.4mg injections achieved an average body weight reduction of 14.9% over 68 weeks, compared to 2.4% with placebo [1]. These results established semaglutide as one of the most effective pharmacological interventions for weight management currently licensed by the MHRA.

Wegovy, the brand name for semaglutide 2.4mg, is administered as a subcutaneous injection once weekly using a pre-filled pen device. Treatment begins at a lower dose (0.25mg) and gradually increases over 16-20 weeks to minimise gastrointestinal side effects whilst your body adjusts to the medication [2].

Why Choose Private Semaglutide Injections Over NHS Routes

Whilst semaglutide is available through the NHS for eligible patients, current demand far exceeds supply. Many Clinical Commissioning Groups have paused new referrals to specialist weight management services, and waiting times for initial consultations can extend beyond 12 months in some regions.

Private semaglutide injections UK services offer immediate access following clinical assessment. At Cured Pharmacy, our UK-registered prescribers review your online consultation typically within 24 hours, and approved treatments are dispatched the same working day for next-day delivery. This means you can begin your weight loss programme within 48 hours of starting your assessment, subject to prescriber approval.

Private treatment also provides flexibility in dosing schedules and ongoing clinical support. Our superintendent pharmacist, Tarun Kumar (GPhC 2233073), and clinical team remain available throughout your treatment journey to address any questions about injection technique, side effect management, or dose adjustments.

Who Can Access Private Semaglutide Treatment

Semaglutide for weight management is licensed for adults with a body mass index (BMI) of 30 kg/m² or above, or 27 kg/m² or above with at least one weight-related comorbidity such as type 2 diabetes, hypertension, or obstructive sleep apnoea [2]. Your prescriber will calculate your BMI during the online consultation and assess your medical history to determine suitability.

Certain medical conditions may preclude semaglutide use, including personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, severe gastrointestinal disease, or diabetic retinopathy. Pregnancy and breastfeeding are also contraindications. A thorough clinical assessment ensures the treatment is both safe and appropriate for your individual circumstances.

Semaglutide Injection Dosing and Treatment Timeline

The standard Wegovy dosing schedule follows a gradual escalation protocol designed to improve tolerability. Treatment begins with 0.25mg once weekly for four weeks, then increases to 0.5mg for four weeks, followed by 1mg, 1.7mg, and finally the maintenance dose of 2.4mg [2]. Each dose increase occurs at four-week intervals, allowing your digestive system to adapt.

This titration schedule is critical for minimising common gastrointestinal side effects such as nausea, vomiting, and diarrhoea. Clinical trials demonstrated that gradual dose escalation reduced treatment discontinuation rates by approximately 40% compared to starting at higher doses [3].

Most patients reach the maintenance dose of 2.4mg by week 17 of treatment. Weight loss typically becomes noticeable within 8-12 weeks, with peak effects observed between 60-68 weeks of continuous treatment. Your UK prescriber may recommend continuing treatment beyond one year if you achieve clinically significant weight loss (≥5% of initial body weight) and tolerate the medication well [1].

Injection Technique and Storage

Wegovy pens are designed for subcutaneous injection into the abdomen, thigh, or upper arm. Each pre-filled pen contains a single dose and includes detailed instructions. You'll rotate injection sites weekly to reduce the risk of lipodystrophy (changes in fat tissue at injection sites).

Unopened Wegovy pens must be stored in a refrigerator at 2-8°C and protected from light. Once in use, pens can be kept at room temperature (below 30°C) for up to 28 days. Never freeze semaglutide, and discard any pens that have been frozen, even if subsequently thawed.

Understanding Semaglutide Side Effects and Management

The most frequently reported side effects of semaglutide are gastrointestinal in nature. In the STEP trials, nausea occurred in approximately 44% of participants, diarrhoea in 30%, vomiting in 24%, and constipation in 24% [1]. These effects are typically mild to moderate, peak during dose escalation phases, and diminish over time as your body adapts.

Practical strategies to manage gastrointestinal symptoms include eating smaller, more frequent meals, avoiding high-fat foods, staying well-hydrated, and taking the injection at a consistent time each week. If side effects become troublesome, your prescriber may recommend maintaining your current dose for an additional four weeks before increasing, or temporarily reducing the dose.

Rare but serious adverse effects include pancreatitis (inflammation of the pancreas), gallbladder disease, and hypoglycaemia in patients also taking other glucose-lowering medications. Seek immediate medical attention if you experience severe persistent abdominal pain, especially if radiating to your back, as this may indicate pancreatitis [2].

Private Semaglutide Injections UK: Pricing and Value

At Cured Pharmacy, Wegovy (semaglutide) is available from £79.00 per pen, significantly lower than typical market rates for private weight loss injections. We believe in transparent upfront pricing—you'll see the exact cost before completing your clinical assessment, with no hidden consultation fees or subscription lock-ins.

The total monthly cost depends on your prescribed dose. During the initial titration phase (weeks 1-16), you'll use lower doses which typically cost less per month. Once you reach the 2.4mg maintenance dose, expect to budget for ongoing monthly treatment as long as you and your prescriber agree continuation is clinically beneficial.

Unlike some private providers, Cured Pharmacy doesn't require annual memberships or minimum purchase commitments. You can order month-by-month based on your needs, and our clinical team will conduct regular reviews (typically every three months) to assess your progress and determine whether continuing treatment remains appropriate.

What's Included in Your Private Treatment

Every private semaglutide prescription through Cured Pharmacy includes a comprehensive clinical consultation by a UK-registered prescriber, genuine MHRA-licensed medication dispensed by our GPhC-registered pharmacy (9012511), discreet packaging with no external branding, and next-day delivery across the UK.

You'll also receive detailed patient information leaflets, injection technique guides, and access to our pharmacy team for ongoing support. There are no consultation fees—the price you see is the price you pay for your medication and complete clinical service.

Starting Your Private Semaglutide Treatment Journey

Beginning treatment is straightforward. Complete our online clinical assessment, which takes under 3 minutes and covers your medical history, current medications, weight loss goals, and any contraindications. A UK-registered prescriber reviews your submission, typically within 24 hours on working days.

If approved, your prescription is sent electronically to our pharmacy team, who dispense your Wegovy and arrange next-day delivery. Your first package will include the starting dose (0.25mg pens), comprehensive instructions, and a treatment schedule outlining when to increase your dose over the coming weeks.

We recommend booking a follow-up with your own GP within the first month of starting treatment, particularly if you have existing medical conditions or take other medications. Whilst our clinical team provides ongoing prescribing support, maintaining communication with your regular healthcare providers ensures coordinated, comprehensive care throughout your weight loss journey.

Many patients achieve significant weight loss with semaglutide when combined with lifestyle modifications including a reduced-calorie diet and increased physical activity. Clinical trials showed that participants who incorporated behavioural interventions alongside medication achieved greater weight reductions than those relying on pharmacotherapy alone [3]. Your prescriber can provide guidance on evidence-based lifestyle strategies to optimise your results.

Scientific References

1. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
2. Novo Nordisk. (2023). Wegovy 2.4 mg solution for injection in pre-filled pen: Summary of Product Characteristics. Medicines and Healthcare products Regulatory Agency. https://www.medicines.org.uk/emc/product/13799 [accessed 13 August 2026]
3. Rubino, D., et al. (2021). Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA, 325(14), 1414–1425. https://doi.org/10.1001/jama.2021.3224 [accessed 13 August 2026]
4. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
5. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
6. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.